Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology

Elsevier / Gold Standard Announces New Drug Class Overviews for Clinical Pharmacology PR Newswire TAMPA, Florida, August 22, 2012 TAMPA, Florida, August 22, 2012 /PRNewswire/ -- Drug Class Overviews revamped to address the changing needs of health care professionals Leading drug information provider Elsevier / Gold Standard announced today its new Drug Class Overviews, making Clinical Pharmacology more valuable at the point of care. Clinical Pharmacology Drug Class Overviews are now even more powerful for evaluating formulary decisions and therapeutic drug substitutions. Elsevier / Gold Standard has improved the speed and usability of the content through bulleted summaries and tables, highlighting a variety of critical areas in drug- interaction information. "The new Drug Class Overviews represent a significant evolution in our content development that was stimulated and driven by input from our clients," said Elsevier / Gold Standard President Marianne Messer. "This advancement also represents the way in which our users wish to utilize our vast amount of drug information that is updated in real-time.